AI assistant
DEXCOM INC — Director's Dealing 2025
Jul 7, 2025
30198_dirs_2025-07-07_70b7af19-ea84-488f-bd5e-ea604dea7476.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2025-05-08
Reporting Person: GALA RENEE D (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-05-08 | Common Stock | A | 1161 | — | Acquired | 6881 | Direct |
Footnotes
F1: The original Form 4, filed on May 12, 2025, is being amended by this Form 4 to correct a calculation error that misreported the number of unvested restricted stock units granted to the reporting person on May 8, 2025. This amendment correctly reports the number of unvested restricted stock units granted to the reporting person on May 8, 2025.
F2: Represents unvested restricted stock units which were granted on May 8, 2025 and shall vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2026 Annual Meeting of Stockholders.
F3: Included in this number are 6,881 unvested restricted stock units, 5,720 of which were granted on March 6, 2025 and shall vest through March 6, 2028 and 1,161 of which were granted on May 8, 2025 and shall vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2026 Annual Meeting of Stockholders.